Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 78.62 Billion | USD 141.52 Billion | 6.2% | 2024 |
FrequentlyAsked Questions
In Global Chronic Respiratory Diseases Treatment Market Report, Chronic respiratory diseases (CRDs) are medical conditions that affect the structures of the lungs including airways.
The global chronic respiratory diseases treatment market is expected to grow due to increasing air pollution, rising prevalence of respiratory disorders, advancements in inhalation therapies, and growing adoption of biologics and personalized medicine.
According to a study, the global chronic respiratory diseases treatment market size was worth around USD 78.62 Billion in 2024 and is expected to reach USD 141.52 Billion by 2034.
The global chronic respiratory diseases treatment market is expected to grow at a CAGR of 6.2% during the forecast period.
North America is expected to dominate the chronic respiratory diseases treatment market over the forecast period.
Leading players in the global chronic respiratory diseases treatment market include AstraZeneca plc, Merck & Co. Inc., Boehringer Ingelheim Pharmaceuticals Inc, GlaxoSmithKline plc, Teva Pharmaceutical Ltd., Mylan N.V., and Sumitomo Dainippon Pharma Co., Ltd, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed